Active treatment, remission, or survivorship — oncology researchers need your blood at every stage. Your biomarkers are driving the next generation of cancer treatments.
Start Earning Now ›Your blood carries data that cannot be created in a laboratory.
Oncology research depends on real patient biomarkers — circulating tumor DNA (ctDNA), tumor-associated antigens, immune response profiles, and treatment response data that only exist in the blood of cancer patients.
This data powers the development of targeted therapies, immunotherapies, early detection methods like liquid biopsy, and companion diagnostics that match patients to the right treatment faster.
Researchers need blood from every stage of the cancer journey — from initial diagnosis through active treatment, into remission, and across long-term survivorship. Each phase carries different biomarker signatures that tell a unique part of the story.
All cancers qualify — these are among the most actively recruited.
Among the highest-paying conditions in the network.
Matched sets pair blood with tumor biopsy from the same donor and command premium compensation. Amounts are estimates set by study sponsors.
Coordinated with your care team for safety.
Common questions from cancer donors.
Your biomarkers are advancing treatments that save lives. Create your profile and see which studies need you.
Get Matched Now ›